About the Authors
- Erick Turner
- Portland VA Medical Center and Oregon Health and Science University, Portland, Oregon, United States of America
- Martin Tramèr
- Geneva University Hospitals, Geneva, Switzerland
EHT is on the speaker's bureaus of Eli Lilly, AstraZeneca, and Bristol-Myers Squibb. He has provided outside consulting to Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Sepracor. He has also received funding for clinical drug trials, which can be spent only for research purposes and which has no effect on his income, from Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, and DOV Pharmaceuticals. MRT has been a scientific consultant to Pfizer, Merck, Janssen-Cilag, and Sintetica. He has also received lecture fees from various pharmaceutical companies.